To Top

Search By Topic

Process Development

14 Articles available
Manufacturing

Facilities for the Future

Christa Myers, Sr. Pharmaceutical Engineering Specialist, CRB

PTV-M01-17-NS-012
Quality by Design (QbD)

Designing a Better Single-Use Facility

PAP-Q1-17-CL-012
Biologics

Investing for Successful Advancement of Viral Vector Manufacturing

PAP-Q1-17-CL-007
Biologics

INNOVATION: Creating Solutions for Healthcare’s Ambitious Agenda

PAP-Q04-16-FA-001
Clinical Trials

Speed-to-Market: Process and Capacity on Demand

PAP-Q04-16-CL-014
CDMO

Achieving Successful Treatment Outcomes Through the Delivery of Manufacturing Services

PAP-Q04-16-CL-012
Biologics

Achieving Continuous Downstream Bioprocessing

PAP-Q04-16-CL-009
API

Accelerating Approval and Reducing Costs of Spray Dried Drugs Through Development by Design (DbD)

PAP-Q03-16-CL-011
API

Growing Demand for Small-Molecule CDMO Services

PAP-Q1-16-CL-004
API

Single-Use Now Key Technology in Biopharmaceutical Manufacturing

POP-M01-16-NI-001
API

What Does It Mean to be a Full-Service CDMO?

PAP-Q4-15-CL-002
Biologics

Biotherapeutics Outpace Conventional Therapies

BIO-M03-12-NI-001
Clinical Trials

Benefit From Clinical Trials In Emerging Markets While Limiting Risk Exposure

LSL-M09-11-NI-001
//Fix for text overflow in cards